Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients

Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients

Circulating tumor cells have a strong potential as a quasi-non-invasive tool for setting up a precision medicine strategy for cancer patients. Using a second-generation “filtration-based” technology to isolate CTCs, the Screencell™ technology (Sarcelles, France), we performed a large and simultaneou...

Full description

Bibliographic Details
Main Authors: Alexia Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, Anaïs Aulas, Maria Lucia Liberatoscioli, Olivier Cabaud, Arnaud Guille, Alexandre de Nonneville, Quentin Da Costa, Emilie Denicolai, Jihane Pakradouni, Anthony Goncalves, Daniel Birnbaum, François Bertucci, Emilie Mamessier
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
circulating tumor cells
breast cancer
metastases
epithelial-to-mesenchymal transition
plasticity
biomarker
Online Access:https://www.mdpi.com/2072-6694/14/4/932

Internet

https://www.mdpi.com/2072-6694/14/4/932

Similar Items